Related Experiment Video
Updated: Jun 24, 2025

Robotic Myotomy and Partial Fundoplication for Achalasia
Published on: August 11, 2023
Cardiovascular Autonomic Deficits in Different Types of Achalasia
Abhijith Anil1, Ritesh K Netam1, Atanu Roy2
1Department of Physiology, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
Achalasia cardia patients show reduced autonomic function, particularly parasympathetic reactivity and sympathetic responses, worsening with disease progression from type II to type I.
Area of Science:
- Gastroenterology
- Neurology
- Cardiology
Background:
- Achalasia cardia is a primary esophageal motility disorder with unknown progression.
- Autonomic dysfunction has not been extensively studied across different achalasia types.
Purpose of the Study:
- To investigate autonomic dysfunction in various types of achalasia.
- To compare autonomic function in achalasia patients with healthy controls.
Main Methods:
- Diagnosis of achalasia using high-resolution esophageal manometry (HRM) based on Chicago classification v4.0.
- Performance of autonomic function tests (AFT) including head-up tilt test, deep breathing test (DBT), Valsalva maneuver (VM), handgrip test (HGT), cold pressor test (CPT), and heart rate variability (HRV) test.
- Comparison of test results between 62 achalasia patients (types I, II, III) and 39 healthy controls.
Main Results:
- All achalasia types exhibited a generalized loss of parasympathetic and baroreflex-independent sympathetic reactivity.
- Baroreflex-dependent cardiovascular adrenergic reactivity remained normal.
- Cardiac autonomic tone showed reduced parasympathetic and sympathetic influence, though sympathovagal balance was maintained.
- Autonomic dysfunction severity was higher in type I, followed by type II achalasia.
Conclusions:
- Achalasia patients demonstrate decreased parasympathetic reactivity, baroreflex-independent sympathetic reactivity, and cardiac autonomic tone compared to controls.
- The severity of autonomic dysfunction correlates with disease progression, being more pronounced in type I than type II achalasia.
Related Concept Videos
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Therapeutic Uses

